drugset / Trial / NCT03012477
CISPLATIN + AZD-1775 In Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This research study is studying a combination of drugs as a possible treatment for triple-negative breast cancer that has spread to other areas of the body. The names of the study interventions involved in this study are: * Cisplatin * AZD1775
Timeline
- Start
- 2017-01-18
- Primary completion
- 2019-05-07
- Completion
- 2020-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adavosertib | Small molecule | 200 mg | Oral |
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | Intravenous |